Streetbeat News

Stock Prices

KDP

Over the past 15 years, Keurig Dr Pepper (NASDAQ:KDP) has produced an average annual return of 19.97%, outperforming the market by 5.74% on an annualized basis. A $100 investment in KDP 15 years ago would now be worth $1,419.75. The company currently has a market capitalization of $40.82 billion.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 5:30 pm

COR

Over the past 5 years, Cencora (NYSE:COR) has outperformed the market with an annualized return of 24.09%, growing a $1000 investment to $2,911.90. Cencora's market capitalization stands at $46.84 billion.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 5:30 pm

PATH

UiPath's (NYSE:PATH) short interest has decreased by 23.89% since the last report, with 18.84 million shares sold short, representing 4.78% of its float. This decrease in short interest could indicate a more bullish sentiment towards the stock among investors. UiPath has a higher short interest compared to its peers, with an average of 4.04% in its peer group.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 5:30 pm

FITB

Fifth Third Bancorp's (NYSE:FITB) short interest has increased by 9.22%, with 18.27 million shares sold short, representing 3.08% of its float. This indicates a bearish market sentiment, although it's not a definitive predictor of stock performance. Compared to its peers, FITB has a higher short interest, suggesting more bearish sentiment among investors towards FITB than its industry counterparts.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 5:30 pm

CTLT

Catalent's (NYSE:CTLT) short interest has decreased by 33.03% since the last report, with 7.45 million shares sold short, representing 5.21% of its float. This decrease in short interest could indicate a more bullish sentiment towards CTLT among investors. Compared to its peers, CTLT has a higher short interest percentage of float (5.21% vs. peer average of 3.11%).

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 5:30 pm

NXST

Nexstar Media Group Inc (NASDAQ:NXST) reported a Q4 fiscal 2023 revenue decline of 12.3% YoY to $1.304 billion, missing expectations due to a slump in political advertising. Despite this, core advertising and distribution revenues showed growth. The company's EPS also fell to $3.32 from $5.30 in Q4 2022. Nexstar aims to maximize shareholder returns, with a 2024 Adjusted EBITDA outlook of $2.085 to $2.195 billion. NXST shares rose 1.5% to $164.84.

Portfolio Pulse from Akanksha Bakshi

February 28, 2024 | 5:29 pm

ADIL

Adial Pharmaceuticals' stock price increased following the announcement of a new patent for AD04, aimed at treating opioid use disorder.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:29 pm

SPY

Fed's Collins remarks on the labor market's condition influencing future decisions, stating it's premature to discuss a rate cut in May. The policy is deemed 'well positioned', allowing for a methodical approach. The baseline expectation is for the Fed to cut rates this year, but Collins warns against overreacting to single data points on inflation.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:27 pm

PAYC

Kari Firestone announced on CNBC that she is adding to her position in Paycom Software, indicating a positive outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:26 pm

ADIL

IAS

INGN

OGEN

VANI

VTVT

U.S. stocks traded lower with the Nasdaq down 50 points. Real estate shares rose by 1.1%, while health care shares fell by 0.8%. U.S. crude oil inventories increased more than expected. Vivani Medical, Adial Pharmaceuticals, and vTv Therapeutics saw significant stock price increases, while Oragenics, Integral Ad Science, and Inogen experienced notable declines.

Portfolio Pulse from Avi Kapoor

February 28, 2024 | 5:25 pm